213225 American Chemical Society Perspective on Professional Integrity

Monday, November 9, 2009: 3:10 PM

Barclay Satterfield, PhD , Senior Policy Associate, Office of Public Policy, American Chemical Society, Washington, DC
This presentation will discuss the American Chemical Society (ACS) perspective on professional integrity and proper use of science in policy decision-making. The American Chemical Society strongly supports the use of insightful and comprehensive scientific and engineering research and analyses to assist the development and evaluation of policy options to deal with the critical and complex challenges our government faces. ACS encourages policies that assist the government to obtain and integrate scientific assessments including transparency, openness, empowerment of scientists inside and outside of government, and an appropriate scientific advisory system.

This presentation will also discuss how these positions influenced ACS becoming a founding member of Professionals for the Public Interest: Associations & Unions Defending Professional Integrity (PftPI). How the issues of professional integrity and proper use of science in policymaking intersect with public health on a number of fronts in the field of chemistry, most notably environmental health and chemicals management policy, will be evaluated.

Learning Objectives:
1. Compare and assess how professional integrity is essential to various professions working on public health issues. 2. Describe the policy positions that led to ACS involvement with PftPI.

Keywords: Professionalism, Policy/Policy Development

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the American Chemical Society advocate covering issues of scientific integrity and use of science in policy decision-making. I have been an active participant in the joint working group Professionals for the Public Interest.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.